Immunoprecise Antibodies
About: ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
Employees: 101
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
225% more call options, than puts
Call options by funds: $26K | Put options by funds: $8K
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0.1% less ownership
Funds ownership: 6.39% [Q1] → 6.29% (-0.1%) [Q2]
14% less funds holding
Funds holding: 22 [Q1] → 19 (-3) [Q2]
35% less capital invested
Capital invested by funds: $2.56M [Q1] → $1.68M (-$883K) [Q2]
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
HC Wainwright & Co. Swayampakula Ramakanth 21% 1-year accuracy 15 / 71 met price target | 1,423%upside $9 | Buy Reiterated | 17 Sept 2024 |
Benchmark Robert Wasserman 58% 1-year accuracy 25 / 43 met price target | 408%upside $3 | Speculative Buy Maintained | 14 Aug 2024 |
HC Wainwright & Co. Swayampakula Ramakanth 21% 1-year accuracy 15 / 71 met price target | 1,423%upside $9 | Buy Reiterated | 30 Jul 2024 |
Financial journalist opinion
Based on 6 articles about IPA published over the past 30 days